FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

John Blum / David Murray / Chad Taylor: The Recursive Tree album review by John Sharpe, published on July 14, 2024. Find thousands jazz reviews at All About Jazz!

Nvidia’s investment isn’t just working capital for Recursion Pharmaceuticals’ technology-driven drug discovery research. Recursion says it will get more computing power as well as the ...

Recursion has a library of 3 trillion searchable genes that will serve as the foundation for the company's AI-powered drug discovery program.

Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline. The deal de-risks the company's pipeline by removing uncertainty; however, there's still a long way to go before REV102 ...

Recursion Pharmaceuticals (RXRX -3.39%) didn't have a fine start to the working week on Monday, at least as far as its stock was concerned. Investors traded out of it following the clinical-stage ...

Aims To examine evidence of QOL response shift in patients with multiple sclerosis (MS) using recursive partitioning tree analysis (RPART) technique. Methods Subjects: MS patients from the NARCOMS ...

John Blum, David Murray and Chad Taylor: The Recursive Tree album review by Troy Dostert, published on June 8, 2024. Find thousands jazz reviews at All About Jazz!